Vivo (technology company)

News and Video Search Results

News coverage

Vilya Announces New Publication in Science Validating Foundational Approach to Design of Novel Chemically Diverse Macrocycles

GlobeNewswire 25 Apr 2024

– Company creating de novo designed macrocycles with enhanced efficacy that precisely target disease biology– Vilya’s..

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer
PR Newswire Asia 25 Apr 2024
Cell Culture Media Market Size Expected to Reach USD 18.50 Bn by 2033
GlobeNewswire 24 Apr 2024
Pixelworks Empowers iQOO Z9 Turbo to Bring Immersive Gaming and Video Experiences to More Consumers
PR Newswire Asia 24 Apr 2024
Catheter Precision, Inc. (VTAK) Announces Receipt of First Purchase Order for LockeT from HCA Healthcare Facility
Accesswire 24 Apr 2024

0 shares 1 views

You might like

Vivo (technology company) media coverage

Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales

Accesswire 24 Apr 2024

*Financial Highlights*

· *Direct MagnetOs sales rose by 155% to CHF 13.9 million in Q1 2024 from CHF 5.4 million in Q1..

DEFENCE’S ACCUTOX ANTI-CANCER ARM-002 VACCINE EXHIBITS POTENT ANTIGEN PRESENTATION
EQS Group 23 Apr 2024
Arbor Biotechnologies to Present Data Supporting Therapeutic Programs in PH1 and ALS, and the Discovery of a Novel Type V Nuclease at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
GlobeNewswire 22 Apr 2024
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
GlobeNewswire 22 Apr 2024
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
GlobeNewswire 22 Apr 2024

Advertisement

More coverage

Excision BioTherapeutics to Present Positive Data from its HSV-1 Keratitis Program, EBT-104, at the ASGCT 2024 Annual Meeting

GlobeNewswire 22 Apr 2024

· Oral presentation to discuss CRISPR-associated gene editing inactivating herpes virus
· Two poster presentations highlight..

CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
GlobeNewswire 22 Apr 2024
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
GlobeNewswire 22 Apr 2024
Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer
PR Newswire Asia 22 Apr 2024
Preliminary Results for the Year Ended 31 December 2023
GlobeNewswire 19 Apr 2024